To further investigate the anti-tumorigenic activity and mechanism of everolimus in vivo, the expression of Ki-67, phosphorylated S6, phosphorylated AKT and cleaved caspase-3 in tumor tissues was evaluated by immunohistochemistry (Figure 6E). The gene discussed is AKT1; the disease is neoplasm.